Management of priming fluids in cardiopulmonary bypass for adult cardiac surgery: network meta-analysis

References

• Patel J, Prajapati M, Solanki A, et al. Comparison of albumin, hydroxyethyl starch and ringer lactate solution as priming fluid for cardiopulmonary bypass in paediatric cardiac surgery. J Clin Diagn Res. 2016;10: 1–15.
   Google Scholar
• Himpe D, Van Cauwelaert P, Neels H, et al. Priming solutions for cardiopulmonary bypass: comparison of three colloids. J Cardiothorac Vasc Anesth. 1991;5(5):457–466. doi: 10.1016/1053-0770(91)90120-i.
   PubMedGoogle Scholar
• Lilley A. The selection of priming fluids for cardiopulmonary bypass in the UK and Ireland. Perfusion. 2002;17(5):315–319. doi: 10.1191/0267659102pf538oa.
   PubMed Web of Science ®Google Scholar
• Baehner T, Boehm O, Probst C, et al. Cardiopulmonary bypass in cardiac surgery. Anaesthesist. 2012;61(10):846–856. doi: 10.1007/s00101-012-2050-0.
   PubMed Web of Science ®Google Scholar
• Gu YJ, Boonstra PW. Selection of priming solutions for cardiopulmonary bypass in adults. Multimed Man Cardiothorac Surg. 2006;2006:001198.
   Google Scholar
• Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72(2):527–533; discussion 534. doi: 10.1016/s0003-4975(01)02745-x.
   PubMed Web of Science ®Google Scholar
• Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transplant. 2013;18:205–217. doi: 10.12659/AOT.889188.
   PubMed Web of Science ®Google Scholar
• Hirleman E, Larson DF. Cardiopulmonary bypass and edema: physiology and pathophysiology. Perfusion. 2008;23(6):311–322. doi: 10.1177/0267659109105079.
   PubMed Web of Science ®Google Scholar
• Miles LF, Coulson TG, Galhardo C, et al. Pump priming practices and anticoagulation in cardiac surgery: results from the global cardiopulmonary bypass survey. Anesth Analg. 2017;125(6):1871–1877. doi: 10.1213/ANE.0000000000002052.
   PubMed Web of Science ®Google Scholar
• Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18(4):429–437. doi: 10.1053/j.jvca.2004.05.019.
   PubMed Web of Science ®Google Scholar
• Beukers AM, de Ruijter JAC, Loer SA, et al. Effects of crystalloid and colloid priming strategies for cardiopulmonary bypass on colloid oncotic pressure and haemostasis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2022;35:ivac127.
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ. Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited. BMC Surg. 2022;22(1):140. doi: 10.1186/s12893-022-01588-x.
   PubMed Web of Science ®Google Scholar
• Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003;54(3):207–215.
   PubMedGoogle Scholar
• Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–784. doi: 10.7326/M14-2385.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
   PubMed Web of Science ®Google Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. doi: 10.1177/0962280216669183.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.
   PubMed Web of Science ®Google Scholar
• Shi J, Luo D, Weng H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020;11:641–654.
   PubMed Web of Science ®Google Scholar
• Jackson D, Barrett JK, Rice S, et al. A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Statist Med. 2014;33(21):3639–3654. doi: 10.1002/sim.6188.
   PubMed Web of Science ®Google Scholar
• Song F, Xiong T, Parekh-Bhurke S, et al. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ. 2011;343:d4909. doi: 10.1136/bmj.d4909.
   PubMedGoogle Scholar
• Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:58. doi: 10.1186/s12874-015-0060-8.
   PubMed Web of Science ®Google Scholar
• Van der Linden PJ, De Hert SG, Daper A, et al. 3.5% Urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth. 2004;51(3):236–241. doi: 10.1007/BF03019102.
   PubMed Web of Science ®Google Scholar
• Choi YS, Shim JK, Hong SW, et al. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010;76:584–591.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh Maleki M, Derakhshan P, Rahmanian Sharifabad A, et al. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 (voluven) on renal function as priming solutions for cardiopulmonary bypass: a randomized double blind clinical trial. Anesth Pain Med. 2016;6(1):e30326. doi: 10.5812/aapm.30326.
   PubMedGoogle Scholar
• Kolsrud O, Barbu M, Dellgren G, et al. Dextran-based priming solution during cardiopulmonary bypass attenuates renal tubular injury – a secondary analysis of randomized controlled trial in adult cardiac surgery patients. Acta Anaesthesiol Scand. 2022;66(1):40–47. doi: 10.1111/aas.13975.
   PubMed Web of Science ®Google Scholar
• Barbu M, Kolsrud O, Ricksten SE, et al. Dextran- versus crystalloid-based prime in cardiac surgery: a prospective randomized pilot study. Ann Thorac Surg. 2020;110(5):1541–1547. doi: 10.1016/j.athoracsur.2020.03.031.
   PubMed Web of Science ®Google Scholar
• Vanhoonacker J, Ongenae M, Vanoverschelde H, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg. 2009;60(2):91–97.
   PubMedGoogle Scholar
• Yap WW, Young D, Pathi V. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass – a randomised controlled trial. Perfusion. 2007;22(1):57–61. doi: 10.1177/0267659107077903.
   PubMed Web of Science ®Google Scholar
• Kamra C, Beney A. Human albumin in extracorporeal prime: effect on platelet function and bleeding. Perfusion. 2013;28(6):536–540. doi: 10.1177/0267659113492836.
   PubMed Web of Science ®Google Scholar
• Kuitunen AH, Hynynen MJ, Vahtera E, et al. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004;98(2):291–297. doi: 10.1213/01.ANE.0000096006.60716.F6.
   PubMed Web of Science ®Google Scholar
• Tiryakioğlu O, Yildiz G, Vural H, et al. Hydroxyethyl starch versus ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008;3:45. doi: 10.1186/1749-8090-3-45.
   PubMed Web of Science ®Google Scholar
• Gurbuz HA, Durukan AB, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg. 2013;8:71. doi: 10.1186/1749-8090-8-71.
   PubMed Web of Science ®Google Scholar
• Svendsen ØS, Farstad M, Mongstad A, et al. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial. Perfusion. 2018;33(6):483–489. doi: 10.1177/0267659117746235.
   PubMed Web of Science ®Google Scholar
• Kuitunen A, Hynynen M, Salmenperä M, et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand. 1993;37(7):652–658. doi: 10.1111/j.1399-6576.1993.tb03783.x.
   PubMed Web of Science ®Google Scholar
• Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann. 2009;17:368–372.
   PubMedGoogle Scholar
• Moerman A, Van Eeckhout C, Vanderstraeten K, et al. The effect of hydroxyethyl starch 6% 130/0.4 compared with gelatin on microvascular reactivity. Anaesthesia. 2016;71(7):798–805. doi: 10.1111/anae.13388.
   PubMed Web of Science ®Google Scholar
• Schramko A, Suojaranta-Ylinen R, Niemi T, et al. The use of balanced HES 130/0.42 during complex cardiac surgery; effect on blood coagulation and fluid balance: a randomized controlled trial. Perfusion. 2015;30(3):224–232. doi: 10.1177/0267659114540022.
   PubMed Web of Science ®Google Scholar
• Tamayo E, Alvarez FJ, Alonso O, et al. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass. Acta Anaesthesiol Scand. 2008;52(9):1204–1212. doi: 10.1111/j.1399-6576.2008.01758.x.
   PubMed Web of Science ®Google Scholar
• Lou S, Bian L, Long C, et al. Does 6% hydroxyethyl starch 130/0.4 impact differently on blood glucose than 4% gelatin in patients receiving open heart surgery? Perfusion. 2012;27(2):113–118. doi: 10.1177/0267659111426920.
   PubMed Web of Science ®Google Scholar
• Schweizer R, Lameche M, Coelembier C, et al. Cardiopulmonary bypass priming with hydroxyethyl starch 6% 130/0.4 or sodium chloride 0.9%: a preliminary Double-Blind randomized controlled study in cardiac surgery. J Cardiothorac Vasc Anesth. 2019;33(12):3534–3535. doi: 10.1053/j.jvca.2019.05.003.
   PubMed Web of Science ®Google Scholar
• Liou HL, Shih CC, Chao YF, et al. Inflammatory response to colloids compared to crystalloid priming in cardiac surgery patients with cardiopulmonary bypass. Chin J Physiol. 2012;55(3):210–218. doi: 10.4077/CJP.2012.BAA028.
   PubMed Web of Science ®Google Scholar
• Shahbazi S, Zeighami D, Allahyary E, et al. Effect of colloid versus crystalloid administration of cardiopulmonary bypass. Prime Solution Tissue Organ Perfusion. 2010;5:e14235.
   Google Scholar
• Adrian K, Mellgren K, Skogby M, et al. The effect of albumin priming solution on platelet activation during experimental long-term perfusion. Perfusion. 1998;13(3):187–191. doi: 10.1177/026765919801300306.
   PubMed Web of Science ®Google Scholar
• Holloway DS, Summaria L, Sandesara J, et al. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988;59(01):062–067. doi: 10.1055/s-0038-1646770.
   PubMedGoogle Scholar
• Finfer S. Reappraising the role of albumin for resuscitation. Curr Opin Crit Care. 2013;19(4):315–320. doi: 10.1097/MCC.0b013e3283632e42.
   PubMed Web of Science ®Google Scholar
• Schramko A, Suojaranta-Ylinen R, Kuitunen A, et al. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth. 2010;104(6):691–697. doi: 10.1093/bja/aeq084.
   PubMed Web of Science ®Google Scholar
• Tseng CH, Chen TT, Wu MY, et al. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care. 2020;24(1):693. doi: 10.1186/s13054-020-03419-y.
   PubMed Web of Science ®Google Scholar
• Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018;14(9):541–557. doi: 10.1038/s41581-018-0044-0.
   PubMed Web of Science ®Google Scholar
• Hecht-Dolnik M, Barkan H, Taharka A, et al. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2009;138(3):703–711. doi: 10.1016/j.jtcvs.2009.02.035.
   PubMed Web of Science ®Google Scholar
• Moret E, Jacob MW, Ranucci M, et al. Albumin-Beyond fluid replacement in cardiopulmonary bypass surgery: why, how, and when? Semin Cardiothorac Vasc Anesth. 2014;18(3):252–259. doi: 10.1177/1089253214535667.
   PubMedGoogle Scholar
• Moeller C, Fleischmann C, Thomas-Rueddel D, et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care. 2016;35:75–83. doi: 10.1016/j.jcrc.2016.04.011.
   PubMed Web of Science ®Google Scholar
• Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139(5):552–563. doi: 10.1001/archsurg.139.5.552.
   PubMedGoogle Scholar
• Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678–688. doi: 10.1001/jama.2013.430.
   PubMed Web of Science ®Google Scholar
• Wise J. Boldt: the great pretender. BMJ. 2013;346:f1738. doi: 10.1136/bmj.f1738.
   PubMedGoogle Scholar
• Zacharowski K, Van Aken H, Marx G, et al. Comments on Reinhart et al.: consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38(9):1556–1557. doi: 10.1007/s00134-012-2641-x.
   PubMed Web of Science ®Google Scholar